|
1
|
Light RW: Pleural effusions. Med Clin
North Am. 95:1055–1070. 2011. View Article : Google Scholar
|
|
2
|
Stathopoulos GT and Kalomenidis I:
Malignant pleural effusion: tumor-host interactions unleashed. Am J
Respir Crit Care Med. 186:487–492. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muzumdar H: Pleural effusion. Pediatr Rev.
33:45–47. 2012. View Article : Google Scholar
|
|
4
|
Bays AM and Pierson DJ: Tuberculous
pleural effusion. Respir Care. 57:1682–1684. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McGrath EE and Anderson PB: Diagnosis of
pleural effusion: a systematic approach. Am J Crit Care.
20:119–128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sutherland JS, Garba D, Fombah AE, et al:
Highly accurate diagnosis of pleural tuberculosis by immunological
analysis of the pleural effusion. PLoS One. 7:e303242012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ye ZJ, Yuan ML, Zhou Q, et al:
Differentiation and recruitment of Th9 cells stimulated by pleural
mesothelial cells in human Mycobacterium tuberculosis
infection. PLoS One. 7:e317102012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meveychuck A, Osadchy A, Chen B and
Shitrit D: Pleural effusion in chronic obstructive pulmonary
medicine (COPD) patients in a medical intensive care unit:
characteristics and clinical implications. Harefuah. 151:198–201.
2552012.(In Hebrew).
|
|
9
|
Froudarakis ME: Pleural effusion in lung
cancer: more questions than answers. Respiration. 83:367–376. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang T, Lv M, Shen S, et al: Cell-free
microRNA expression profiles in malignant effusion associated with
patient survival in non-small cell lung cancer. PLoS One.
7:e432682012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morgensztern D, Waqar S, Subramanian J,
Trinkaus K and Govindan R: Prognostic impact of malignant pleural
effusion at presentation in patients with metastatic non-small-cell
lung cancer. J Thorac Oncol. 7:1485–1489. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cha SI, Shin KM, Jeon KN, et al: Clinical
relevance and characteristics of pleural effusion in patients with
Mycoplasma pneumoniae pneumonia. Scand J Infect Dis.
44:793–797. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fernández de Larrea C, Duplat A,
Giampietro F, et al: Diagnostic accuracy of immunological methods
in patients with tuberculous pleural effusion from Venezuela.
Invest Clin. 52:23–34. 2011.PubMed/NCBI
|
|
14
|
Botana-Rial M, Casado-Rey P,
Leiro-Fernández V, Andrade-Olivié M, Represas-Represas C and
Fernández-Villar A: Validity of procalcitonin and C-reactive
protein measurement when differentiating between benign and
malignant pleural effusion. Clin Lab. 57:373–378. 2011.PubMed/NCBI
|
|
15
|
Porcel JM, Bielsa S, Esquerda A,
Ruiz-González A and Falguera M: Pleural fluid C-reactive protein
contributes to the diagnosis and assessment of severity of
parapneumonic effusions. Eur J Intern Med. 23:447–450. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Porcel JM: Pearls and myths in pleural
fluid analysis. Respirology. 16:44–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Chen Z, Chen J, et al: The
diagnostic value of apolipoprotein E in malignant pleural effusion
associated with non-small cell lung cancer. Clin Chim Acta.
421:230–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Wang C, Huang X, Shen Y, Shen J
and Ying K: Differential proteome profiling of pleural effusions
from lung cancer and benign inflammatory disease patients. Biochim
Biophys Acta. 1824:692–700. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park DS, Kim D, Hwang KE, et al:
Diagnostic value and prognostic significance of pleural C-reactive
protein in lung cancer patients with malignant pleural effusions.
Yonsei Med J. 54:396–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heffner JE: Diagnosis and management of
malignant pleural effusions. Respirology. 13:5–20. 2008.
|
|
21
|
Hyun TS, Barnes M and Tabatabai ZL: The
diagnostic utility of D2–40, calretinin, CK5/6, desmin and MOC-31
in the differentiation of mesothelioma from adenocarcinoma in
pleural effusion cytology. Acta Cytol. 56:527–532. 2012.
|
|
22
|
Bass LC, Dillard TA, Forseen CJ and Davis
WB: An unusual cause of massive pleural effusion. Am J Med Sci.
344:505–507. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toworakul C, Kasitanon N, Sukitawut W,
Wichinun R and Louthrenoo W: Usefulness of pleural effusion
antinuclear antibodies in the diagnosis of lupus pleuritis. Lupus.
20:1042–1046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elsammak MY, Attia A, Hassan HA, Zaytoun
TM, Shorman M and Suleman M: Evaluation of pleural fluid human
epididymis 4 (HE4) as a marker of malignant pleural effusion.
Tumour Biol. 33:1701–1707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Li ZN, Bao QL, Ge LP, Li XQ and Chen
P: Evaluation of pleural fluid survivin and XIAP for the diagnosis
of malignant pleural effusion. Tumour Biol. 33:1803–1810. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Trapé J, Molina R, Sant F, et al:
Diagnostic accuracy of tumour markers in serous effusions: a
validation study. Tumour Biol. 33:1661–1668. 2012.PubMed/NCBI
|
|
27
|
Davidsen JR, Laursen CB and Madsen PH:
Measuring pH in pleural fluid is valuable when identifying the
cause of purulent pleural effusion. Ugeskr Laeger. 174:1469–1470.
2012.(In Danish).
|
|
28
|
Porcel JM: Pleural fluid biomarkers:
beyond the Light criteria. Clin Chest Med. 34:27–37. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin MY, Liu WY, Tolan AM, Aboulian A,
Petrie BA and Stabile BE: Preoperative serum albumin but not
prealbumin is an excellent predictor of postoperative complications
and mortality in patients with gastrointestinal cancer. Am Surg.
77:1286–1289. 2011.PubMed/NCBI
|
|
30
|
Kawai H: Low perioperative prealbumin
level predicts early recurrence after curative pulmonary resection
for non-small cell lung cancer. World J Surg. 37:20062013.
View Article : Google Scholar
|
|
31
|
Guerra LT, Rosa AR, Romani RF, Gurski RR,
Schirmer CC and Kruel CD: Serum transferrin and serum prealbumin as
markers of response to nutritional support in patients with
esophageal cancer. Nutr Hosp. 24:241–242. 2009.PubMed/NCBI
|
|
32
|
Pinilla JC, Hayes P, Laverty W, Arnold C
and Laxdal V: The C-reactive protein to prealbumin ratio correlates
with the severity of multiple organ dysfunction. Surgery.
124:799–806. 1998. View Article : Google Scholar : PubMed/NCBI
|
